SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Clinical trials for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug beat metformin for antipsychotic weight gain?
Disease control Not yet recruitingThis study compares dapagliflozin and metformin for managing weight gain caused by antipsychotic medications. About 110 adults aged 16 and older will take one of the drugs plus lifestyle advice for 26 weeks. The goal is to see which drug works better and is safer for weight contr…
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE4 • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could lowering antipsychotic doses help some schizophrenia patients function better?
Disease control Not yet recruitingThis study tests whether carefully reducing antipsychotic medication in stable schizophrenia patients can improve their daily functioning compared to staying on the same dose. Researchers will group 288 adults aged 18–60 by their specific psychosis type and randomly assign them t…
Matched conditions: SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC